| MeSH term | MeSH ID | Detail |
|---|---|---|
| Diabetes Mellitus | D003920 | 90 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Fatty Liver | D005234 | 48 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Nervous System Diseases | D009422 | 37 associated lipids |
| Movement Disorders | D009069 | 3 associated lipids |
| Fever | D005334 | 35 associated lipids |
| Catalepsy | D002375 | 30 associated lipids |
| Death, Sudden | D003645 | 12 associated lipids |
| Tremor | D014202 | 15 associated lipids |
Decanoic acid
Decanoic acid is a lipid of Fatty Acyls (FA) class. Decanoic acid is associated with abnormalities such as Hashimoto Disease, Perisylvian syndrome, Parasitic Diseases, Acute myocardial infarction and Myocardial Infarction. The involved functions are known as Cell Differentiation process, Inflammation, Process, Subtraction process and Pressure- physical agent. Decanoic acid often locates in Epithelium, Tissue membrane, Body tissue, Membrane and Organelles. The associated genes with Decanoic acid are Genome, FATE1 gene, HTR3A wt Allele, FFAR1 gene and O3FAR1 gene. The related lipids are Membrane Lipids, Fatty Acids, Micelles, Stearic acid and rac-glycerol 1-monodecanoate.
Cross Reference
Introduction
To understand associated biological information of Decanoic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Decanoic acid?
Decanoic acid is suspected in Hashimoto Disease, Perisylvian syndrome, Parasitic Diseases, Acute myocardial infarction, Myocardial Infarction and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Am. J. Physiol. Gastrointest. Liver Physiol. (1)
- Am. J. Physiol. Heart Circ. Physiol. (1)
- J. Biol. Chem. (1)
- Others (1)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Decanoic acid
PubChem Associated disorders and diseases
What pathways are associated with Decanoic acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Decanoic acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Decanoic acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Decanoic acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Decanoic acid?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Decanoic acid?
Related references are published most in these journals:
- J. Biol. Chem. (3)
- Am. J. Physiol. Gastrointest. Liver Physiol. (1)
- Am. J. Physiol. Heart Circ. Physiol. (1)
- Others (5)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Decanoic acid?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Decanoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| pmid:6613612 | ||||
| pmid:26129951 | ||||
| pmid:21954937 | ||||
| pmid: | ||||
| pmid:16466902 | ||||
| pmid:21360616 | ||||
| Brayden DJ and Walsh E | Efficacious intestinal permeation enhancement induced by the sodium salt of 10-undecylenic acid, a medium chain fatty acid derivative. | 2014 | AAPS J | pmid:24961919 |
| Lv XY et al. | Enhancement of sodium caprate on intestine absorption and antidiabetic action of berberine. | 2010 | AAPS PharmSciTech | pmid:20237966 |
| Liu DS et al. | Quantum dot targeting with lipoic acid ligase and HaloTag for single-molecule imaging on living cells. | 2012 | ACS Nano | pmid:23181687 |
| Nguyen TD et al. | Shape- and size-controlled synthesis of monoclinic ErOOH and cubic Er2O3 from micro- to nanostructures and their upconversion luminescence. | 2010 | ACS Nano | pmid:20373749 |
| Misurec J et al. | Computerized EEG in the comparison of oxyprothepin and fluphenazine decanoat. | 1979 | Act Nerv Super (Praha) | pmid:42262 |
| Zbytovský J and Zapletálek M | Longitudinal study of the effect, tolerance and undesired side effects of injection haloperidol decanoate applied in different psychiatric indications. | 1989 | Act Nerv Super (Praha) | pmid:2638106 |
| Alda M et al. | Pharmacokinetic properties of haloperidol decanoate. | 1989 | Act Nerv Super (Praha) | pmid:2571223 |
| Zapletálek M and Zbytovský J | Haloperidol decanoate in the treatment of schizophrenia. | 1989 | Act Nerv Super (Praha) | pmid:2571224 |
| Zbytovský J and Zapletálek M | Haloperidol decanoate in the treatment of sexual deviations. | 1989 | Act Nerv Super (Praha) | pmid:2571225 |
| Drtil J | Treatment of patients dependent on tobacco with fluphenazine decanoate. | 1989 | Act Nerv Super (Praha) | pmid:2800941 |
| Caffier G et al. | [Influence of homologous n-alkanoic on functional properties of isolated skeletal muscles. II. Membrane resting potential and the osmotic effectiveness of alkanoic acid]. | 1976 | Acta Biol. Med. Ger. | pmid:1035456 |
| Lee C et al. | Decanoic acid-modified glycol chitosan hydrogels containing tightly adsorbed palmityl-acylated exendin-4 as a long-acting sustained-release anti-diabetic system. | 2014 | Acta Biomater | pmid:24140611 |
| Wang H | Bis(μ-2-carb-oxy-5-nitro-benzoato-κO:O)bis-[(2,2'-bipyridine-κN:N')chloridocopper(II)] dihydrate. | 2012 | Acta Crystallogr Sect E Struct Rep Online | pmid:22346893 |
| Llovera L et al. | 1-(4-Chloro-phen-yl)-3-(2-meth-oxy-anilino)propan-1-one. | 2011 | Acta Crystallogr Sect E Struct Rep Online | pmid:21523002 |
| Ahmad Tajidi NS et al. | Diaqua-(1,4,8,11-tetra-aza-cyclo-tetra-decane-κN,N,N,N)copper(II) dideca-noate dihydrate. | 2010 | Acta Crystallogr Sect E Struct Rep Online | pmid:21588133 |
| Llovera L et al. | 8-Meth-oxy-4-(4-methoxy-phen-yl)quinoline. | 2009 | Acta Crystallogr Sect E Struct Rep Online | pmid:21580002 |
| MartÃnez R et al. | 3-Hydr-oxy-5,5-dimethyl-2-(2-oxo-propyl)cyclo-hex-2-enone. | 2009 | Acta Crystallogr Sect E Struct Rep Online | pmid:21578898 |
| Lejon S et al. | Structural basis for the binding of naproxen to human serum albumin in the presence of fatty acids and the GA module. | 2008 | Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. | pmid:18259051 |
| Schuurs AH et al. | Experimental work with anabolics in autoimmunity models. | 1985 | Acta Endocrinol Suppl (Copenh) | pmid:3865485 |
| Lemos J et al. | [Neuroleptic malignant syndrome: a rare long lasting case report]. | 2010 Nov-Dec | Acta Med Port | pmid:21627894 |
| Paolucci S et al. | Treatment of Gilles de la Tourette syndrome with depot neuroleptics. | 1984 | Acta Neurol (Napoli) | pmid:6591768 |
| La Mura G et al. | [Treatment of psychoses with a long-acting neuroleptic agent (fluphenazine decanoate). Clinico-psychopathological study of 53 patients]. | 1974 Jul-Aug | Acta Neurol (Napoli) | pmid:4615572 |
| Zhou W et al. | Intestinal absorption of forsythoside A in in situ single-pass intestinal perfusion and in vitro Caco-2 cell models. | 2012 | Acta Pharmacol. Sin. | pmid:22773077 |
| Curbelo HM et al. | Effects of anabolic-androgenic steroids on hair waves in castrated mice. | 1988 | Acta Physiol Pharmacol Latinoam | pmid:3273624 |
| BLOMSTRAND R | Transport form of decanoic acid-1-14C in the lymph during intestinal absorption in the rat. | 1955 | Acta Physiol. Scand. | pmid:13258301 |
| Kumar A et al. | Synthesis, antimicrobial evaluation, QSAR and in Silico ADMET studies of decanoic acid derivatives. | 2011 Mar-Apr | Acta Pol Pharm | pmid:21485292 |
| Kezutyte T et al. | Study of tolnaftate release from fatty acids containing ointment and penetration into human skin ex vivo. | 2011 Nov-Dec | Acta Pol Pharm | pmid:22125963 |
| Ellerman LA | [Open clinical trial with haloperidol decanoate in patients with psychotic disorders]. | 1987 | Acta Psiquiatr Psicol Am Lat | pmid:3321918 |
| Pérez C and Stier Rosner SE | [Haloperidol decanoate: results of a 6-month open trial in paranoid schizophrenia]. | 1989 Jul-Dec | Acta Psiquiatr Psicol Am Lat | pmid:2576990 |
| Marchant N et al. | [Evaluation of the efficacy of haloperidol decanoate in the treatment of chronic psychotic hospital patients]. | 1985 | Acta Psiquiatr Psicol Am Lat | pmid:2864788 |
| Youssef HA | [Haloperidol decanoate in replacing combinations of antipsychotic agents in the treatment of chronic schizophrenics]. | 1984 | Acta Psiquiatr Psicol Am Lat | pmid:6152573 |
| Alvarez JV and Li Gambi M | [Evaluation of the efficacy of haloperidol decanoate]. | 1986 | Acta Psiquiatr Psicol Am Lat | pmid:2884807 |
| Lagomarsino AJ | [Haloperidol decanoate in psychotic patients]. | 1987 | Acta Psiquiatr Psicol Am Lat | pmid:3442249 |
| Parent M et al. | [Pharmacokinetic of haloperidol decanoate in psychotic patients (author's transl)]. | 1981 Jul-Aug | Acta Psychiatr Belg | pmid:7331843 |
| Wouters J | A six-month follow-up of refractory chronic psychotics treated with Haldol-AID. | 1978 Mar-Apr | Acta Psychiatr Belg | pmid:354327 |
| Stevens B | The social value of fluphenazine decanoate. | 1976 Sep-Oct | Acta Psychiatr Belg | pmid:799897 |
| Evrard E et al. | [Action of flupentixol decanoate in chronic psychoses of the schizophrenic type]. | 1972 | Acta Psychiatr Belg | pmid:4669430 |
| Gross H et al. | Eleven years of experience with depot neuroleptics. | 1981 Mar-Apr | Acta Psychiatr Belg | pmid:6117183 |
| Conde-Lopez VJ | Psycho-social aspects of treatment with long-acting neuroleptics in Spain. | 1981 Mar-Apr | Acta Psychiatr Belg | pmid:6117184 |
| Cassano GB and Placidi GF | The use of long-acting neuroleptics in the acute psychoses. | 1981 Mar-Apr | Acta Psychiatr Belg | pmid:6117187 |
| Fiolet J | Experience with depot neuroleptics in ambulatory practice. | 1981 Mar-Apr | Acta Psychiatr Belg | pmid:6117188 |
| Haring C et al. | Social aspects of therapy with depot neuroleptics in the Federal Republic of Germany. | 1981 Mar-Apr | Acta Psychiatr Belg | pmid:6117189 |
| Roose K | Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses. | 1982 Mar-Apr | Acta Psychiatr Belg | pmid:7180558 |
| Capstick N | Long-term fluphenazine decanoate maintenance dosage requirements of chronic schizophrenic patients. | 1980 | Acta Psychiatr Scand | pmid:7376929 |
| Deberdt R et al. | Intramuscular haloperidol decanoate for neuroleptic maintenance therapy. Efficacy, dosage schedule and plasma levels. An open multicenter study. | 1980 | Acta Psychiatr Scand | pmid:7468294 |
| Fernando J et al. | The use of depot neuroleptic haloperidol decanoate. | 1984 | Acta Psychiatr Scand | pmid:6702478 |
| Wistedt B | A depot neuroleptic withdrawal study. A controlled study of the clinical effects of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients. | 1981 | Acta Psychiatr Scand | pmid:7032224 |
| Denham J and Adamson L | The contribution of fluphenazine enanthate and decanoate in the prevention of readmission of schizophrenic patients. | 1971 | Acta Psychiatr Scand | pmid:4336483 |
| Pinto R et al. | A double-blind comparison of flupenthixol decanoate and fluphenazine decanoate in the treatment of chronic schizophrenia. | 1979 | Acta Psychiatr Scand | pmid:390972 |
| Johnson DA and Breen M | Weight changes with depot neuroleptic maintenance therapy. | 1979 | Acta Psychiatr Scand | pmid:463589 |
| Frangos H et al. | Double-blind therapeutic evaluation of fluspirilene compared with fluphenazine decanoate in chronic schizophrenics. | 1978 | Acta Psychiatr Scand | pmid:354331 |
| Haslam MT et al. | A comparative trail of fluphenazine decanoate and flupenthixol decanoate. | 1975 | Acta Psychiatr Scand | pmid:1091124 |
| Johnson DA and Malik NA | A double-blind comparison of fluphenazine decanoate and flupenthixol decanoate in the treatment of acute schizophrenia. | 1975 | Acta Psychiatr Scand | pmid:1096536 |
| Dencker SJ et al. | Three years' maintenance neuroleptic treatment in schizophrenia--before and beyond. | 1978 | Acta Psychiatr Scand | pmid:24981 |
| Dencker SJ et al. | How schizophrenic patients change during 3 years' treatment with depot neuroleptics. | 1978 | Acta Psychiatr Scand | pmid:24982 |
| Clarke DJ and Ford R | Treatment of refractory Tourette syndrome with haloperidol decanoate. | 1988 | Acta Psychiatr Scand | pmid:3164570 |
| Wistedt B and Ranta J | Comparative double-blind study of flupenthixol decanoate and fluphenazine decanoate in the treatment of patients relapsing in a schizophrenic symptomatology. | 1983 | Acta Psychiatr Scand | pmid:6349256 |
| Eberhard G and Hellbom E | Haloperidol decanoate and flupenthixol decanoate in schizophrenia. A long-term double-blind cross-over comparison. | 1986 | Acta Psychiatr Scand | pmid:3788652 |
| Viukari M et al. | Tolerance and serum levels of haloperidol during parenteral and oral haloperidol treatment in geriatric patients. | 1982 | Acta Psychiatr Scand | pmid:7080851 |
| Knudsen P et al. | Perphenazine decanoate vs. perphenazine enanthate: efficacy and side effects in a 6 week double-blind, comparative study of 50 drug monitored psychotic patients. | 1985 | Acta Psychiatr Scand Suppl | pmid:3907278 |
| Knudsen P et al. | Long-term depot neuroleptic treatment with perphenazine decanoate. I. Efficacy and side effects in a 12 month study of 42 drug monitored psychotic patients. | 1985 | Acta Psychiatr Scand Suppl | pmid:3907279 |
| Knudsen P et al. | Long-term depot neuroleptic treatment with perphenazine decanoate. II. Different depot intervals in the last 6 months of a 12 month study of 42 drug monitored psychotic patients. | 1985 | Acta Psychiatr Scand Suppl | pmid:3934921 |
| Dencker SJ et al. | A controlled one-year study of pipotiazine palmitate and fluphenazine decanoate in chronic schizophrenic syndromes. Evaluation of results at 6 and 12 months' trial. | 1973 | Acta Psychiatr Scand Suppl | pmid:4147508 |
| Knudsen P | Chemotherapy with neuroleptics. Clinical and pharmacokinetic aspects with a particular view to depot preparations. | 1985 | Acta Psychiatr Scand Suppl | pmid:2866666 |
| Knudsen P et al. | Perphenazine decanoate in sesame oil vs. perphenazine enanthate in sesame oil: a comparative study of pharmacokinetic properties and some clinical implications. | 1985 | Acta Psychiatr Scand Suppl | pmid:3865500 |
| Knudsen P et al. | Pharmacokinetic implications of different oil vehicles used in depot neuroleptic treatment. | 1985 | Acta Psychiatr Scand Suppl | pmid:3865501 |
| Meco G et al. | Neuroendocrine effects of haloperidol decanoate in patients with chronic schizophrenia. | 1985 | Adv. Biochem. Psychopharmacol. | pmid:4025041 |
| Dysken MW et al. | Plasma levels and therapeutic efficacy of fluphenazine hydrochloride and decanoate. | 1980 | Adv. Biochem. Psychopharmacol. | pmid:6105804 |
| Wiles DH and Gelder MG | Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate. | 1980 | Adv. Biochem. Psychopharmacol. | pmid:7405678 |
| Maher S et al. | Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic. | 2009 | Adv. Drug Deliv. Rev. | pmid:19800376 |
| Rosengarten H et al. | Diminished D2 dopamine receptor function and the emergence of repetitive jaw movements. | 1988 | Adv. Exp. Med. Biol. | pmid:2976249 |
| Ruelius HW et al. | Reactions of oxaprozin-1-O-acyl glucuronide in solutions of human plasma and albumin. | 1986 | Adv. Exp. Med. Biol. | pmid:3766273 |
| Stuyt EB et al. | Differing effects of antipsychotic medications on substance abuse treatment patients with co-occurring psychotic and substance abuse disorders. | Am J Addict | pmid:16595355 | |
| van Praag HM and Dols LC | Fluphenazine enanthate and fluphenazine decanoate: a comparison of their duration of action and motor side effects. | 1973 | Am J Psychiatry | pmid:4576449 |
| Kane JM et al. | A multidose study of haloperidol decanoate in the maintenance treatment of schizophrenia. | 2002 | Am J Psychiatry | pmid:11925292 |
| Gelenberg AJ et al. | Acute extrapyramidal reactions with fluphenazine hydrochloride and fluphenazine decanoate. | 1979 | Am J Psychiatry | pmid:367182 |
| Gitlin M et al. | Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia. | 2001 | Am J Psychiatry | pmid:11691689 |
| Idzorek S | Antiparkinsonian agents and fluphenazine decanoate. | 1976 | Am J Psychiatry | pmid:1247126 |
| Cleary MF | Fluphenazine decanoate during pregnancy. | 1977 | Am J Psychiatry | pmid:869065 |
| Kane J et al. | Comparison of the incidence and severity of extrapyramidal side effects with fluphenazine enanthate and fluphenazine decanoate. | 1978 | Am J Psychiatry | pmid:717574 |
| Zubenko G and Pope HG | Management of a case of neuroleptic malignant syndrome with bromocriptine. | 1983 | Am J Psychiatry | pmid:6650696 |
| Inderbitzin LB et al. | Fluphenazine decanoate: a clinical problem? | 1989 | Am J Psychiatry | pmid:2563210 |
| Tune LE et al. | Low neuroleptic serum levels in patients receiving fluphenazine decanoate. | 1980 | Am J Psychiatry | pmid:6101523 |
| Chouinard G et al. | Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: extrapyramidal symptoms and therapeutic effect. | 1982 | Am J Psychiatry | pmid:6120655 |
| Turns DM et al. | Depot neuroleptics for acutely psychotic patients. | 1987 | Am J Psychiatry | pmid:2886066 |
| Schiff AA | Fluphenazine decanoate and tardive dyskinesia. | 1982 | Am J Psychiatry | pmid:6124136 |
| Siris SG et al. | Adjunctive imipramine maintenance treatment in schizophrenic patients with remitted postpsychotic depression. | 1989 | Am J Psychiatry | pmid:2817126 |
| Siris SG et al. | Postpsychotic depression and negative symptoms: an investigation of syndromal overlap. | 1988 | Am J Psychiatry | pmid:3057924 |
| Siris SG et al. | Comparative side effects of imipramine, benztropine, or their combination in patients receiving fluphenazine decanoate. | 1983 | Am J Psychiatry | pmid:6346910 |
| Cerimele JM et al. | Psychosis following excessive ingestion of energy drinks in a patient with schizophrenia. | 2010 | Am J Psychiatry | pmid:20194494 |
| Gomez EA | Hypersexuality in men receiving fluphenazine decanoate. | 1981 | Am J Psychiatry | pmid:7196699 |
| Siris SG et al. | Plasma imipramine concentrations in patients receiving concomitant fluphenazine decanoate. | 1982 | Am J Psychiatry | pmid:7055248 |
| Waddington JL | Tardive dyskinesia, fluphenazine decanoate, and haloperidol. | 1982 | Am J Psychiatry | pmid:7072867 |
| Csernansky JG et al. | Fluphenazine decanoate and tardive dyskinesia: a possible association. | 1981 | Am J Psychiatry | pmid:7294195 |